As of 2025-03-21, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 54.78 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -52.9%.
The range of the Relative Valuation is 43.46 - 71.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.7x - 35.3x | 27.1x |
| Forward P/E multiples | 21.7x - 31.1x | 25.1x |
| Fair Price | 43.46 - 71.42 | 54.78 |
| Upside | -62.6% - -38.6% | -52.9% |
| Date | P/E |
| 2025-02-06 | 60.80 |